Teva, Taro Target UK

Israeli drugmakers Teva and Taro are to expand activities in the UK. Teva - the world's largest generics firm - has signed a deal with Schering-Plough to co-promote products for Inflammatory Bowel Disease (IBD) for the UK market. Meanwhile, Taro has secured two approvals for generic formulations of branded products made by two UK

To read the full article, please choose one of the following options: